We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Challenges Patent Covering Solodyn Drug
Barr Challenges Patent Covering Solodyn Drug
January 6, 2009
Medicis Pharmaceutical has received notice that Barr Laboratories has filed an ANDA to market a generic version of Medicis’ once-daily, oral acne treatment Solodyn — a drug that is also the subject of a citizen petition.